Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  OTC Bulletin Board  >  Windtree Therapeutics Inc       

WINDTREE THERAPEUTICS INC

SummaryNewsCalendarCompany 
Business Summary
Windtree Therapeutics, Inc., formerly Discovery Laboratories, Inc., is a biotechnology company. The Company is focused on developing KL4 surfactant therapies for respiratory diseases and other potential applications. The Company operates through the research and development of products focused on surfactant therapies for respiratory disorders and diseases, and the manufacture and commercial sales of approved products segment. The Company's technology platform includes a synthetic, peptide-containing surfactant (KL4 surfactant) that is structurally similar to endogenous pulmonary surfactant, and drug delivery technologies being developed to enable non-invasive administration of aerosolized KL4 surfactant. The Company's core development program, AEROSURF (lucinactant for inhalation), is focused on improving the management of respiratory distress syndrome (RDS) in premature infants, a respiratory condition that can result in long-term respiratory problems, developmental delay and death.
Managers
NameAgeSinceTitle
Craig E. Fraser542016President, Chief Executive Officer & Director
John R. Leone, MBA722012Co-Chairman
Zuie Chin Huang, MBA532018Co-Chairman
John Andrew Tattory, CPA542008Chief Financial Officer & Senior Vice President
Steven G. Simonson, MD612014Chief Medical Officer & Senior Vice President
Bruce A. Peacock, CPA672010Independent Non-Executive Director
Joseph M. Mahady, MBA662013Independent Non-Executive Director
Brian Schreiber, MD-2018Director
Mary B. Templeton732006Secretary, Senior Vice President & General Counsel
Ronald L. Dundore, PhD64-Executive Director-Regulatory Affairs & Quality
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Stock A 1 32,188,929 6,854,014 21.3% 74 0.0% 21.3%
Shareholders
NameEquities%
Lee's Pharmaceutical Holdings Ltd. 12,794,970 39.9%
Panacea Venture 4,527,345 14.1%
Kleiner Perkins Caufield & Byers LLC 4,336,790 13.5%
Broadfin Capital LLC 145,387 0.45%
Zuie Chin Huang, MBA 114,415 0.36%
Craig E. Fraser 84,423 0.26%
Deerfield Management Company LP 71,111 0.22%
Steven G. Simonson, MD 40,712 0.13%
John Andrew Tattory, CPA 36,916 0.12%
Alyeska Investment Group LP 34,029 0.11%
Company contact information
Windtree Therapeutics, Inc.
2600 Kelly Road
Suite 100
Warrington, PA 18976-3622

Phone : +1.215.488.9300
Fax : +1.215.488.9301
Web : http://www.windtreetx.com
Sector Biotechnology & Medical Research - NEC
Connections : Windtree Therapeutics Inc
PanOptica, Inc.
Carisma Therapeutics, Inc.
OriGene Technologies, Inc.
JHL Biotech, Inc.
SV Health Investors LLC
Othera Pharmaceuticals, Inc.
Life Sciences Pennsylvania
Smooth Prosper Ltd.
OMNI Pharmaceuticals (USA), Inc.
Zenesis Ltd.
CVie Therapeutics Co. Ltd.
XW Laboratories, Inc.
Wuhan Kindstar Co. Ltd.
Invisible Sentinel, Inc.
GenScript Corp.
Oscient Pharmaceuticals Corp.
Sigma-Tau Pharmaceuticals, Inc.
Sapphire Therapeutics, Inc.
Pennsylvania State Bar Association
Aro Biotherapeutics Co.
Pernix Therapeutics Holdings, Inc.
Elan Corp. Plc /Abelcet North American Operations/
Madryn Asset Management LP
Chatham College
Kleiner Perkins Caufield & Byers China
New York State Bar Association
KPCB China Fund II LP